{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:51:01Z","timestamp":1759092661948,"version":"3.41.2"},"reference-count":53,"publisher":"The Endocrine Society","issue":"1","license":[{"start":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T00:00:00Z","timestamp":1602892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:label\/>\n                  <jats:p>Limited evidence on treatment options for polycystic ovarian syndrome (PCOS) has led to considerable variation in health care practices. We aimed to compare the effects of metformin and\/or oral contraceptive pills (OCP) in combination with pioglitazone, spironolactone, flutamide, and lifestyle interventions among adolescents aged 11 to 19 years with PCOS. Literature searches were performed in Medline, Embase, and the Cochrane Central Register of Controlled Trials from database inception through December 2018, with no language restriction. Two reviewers screened titles and abstracts, assessed full text eligibility, and extracted information from eligible trials. Evidence was synthesized through network meta-analyses (NMA) using a Bayesian random-effects approach. We identified 37 randomized controlled trials, in which 2400 patients were randomized. NMA showed no statistically important difference among all interventions to improve menstrual regulation or body mass index. Moderate-quality evidence showed hirsutism scores were reduced by multiple interventions that included single and combination medications namely; lifestyle intervention, metformin, OCP, spironolactone, pioglitazone, metformin-OCP, metformin-spironolactone, and metformin-flutamide against placebo. Moderate-quality evidence showed OCP results in more dysglycemia compared to metformin (odds ratio, 2.98; 95% credible interval, 1.02-8.96), no intervention resulted in dysglycemia reduction. In conclusion, metformin and OCP as monotherapy or in combination with other interventions compared with placebo can reduce hirsutism scores, but none of these medications lead to effective menstrual cycle regulation or weight reduction. However, the use of OCP leads to worse cardiometabolic risk factors. Further research into new treatment options is urgently needed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PROSPERO registration number<\/jats:title>\n                  <jats:p>CRD42015016148.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jendso\/bvaa155","type":"journal-article","created":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T19:54:49Z","timestamp":1602964489000},"source":"Crossref","is-referenced-by-count":18,"title":["Efficacy of Treatments for Polycystic Ovarian Syndrome Management in Adolescents"],"prefix":"10.1210","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5304-3528","authenticated-orcid":false,"given":"Reem A","family":"Al Khalifah","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Endocrinology and Metabolism, College of Medicine, King Saud University, Riyadh, Saudi Arabia"},{"name":"Department of Health Research Methodology, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0751-8932","authenticated-orcid":false,"given":"Ivan D","family":"Florez","sequence":"additional","affiliation":[{"name":"Department of Health Research Methodology, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"},{"name":"Department of Pediatrics, Universidad de Antioquia, Medell\u00edn, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3069-1159","authenticated-orcid":false,"given":"Michael J","family":"Zoratti","sequence":"additional","affiliation":[{"name":"Department of Health Research Methodology, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3691-5400","authenticated-orcid":false,"given":"Brittany","family":"Dennis","sequence":"additional","affiliation":[{"name":"Department of Health Research Methodology, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"},{"name":"Department of medicine, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0355-9734","authenticated-orcid":false,"given":"Lehana","family":"Thabane","sequence":"additional","affiliation":[{"name":"Department of Health Research Methodology, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"},{"name":"Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada"},{"name":"Department of Pediatrics and Anesthesia, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ereny","family":"Bassilious","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Endocrinology and Metabolism, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2020,10,17]]},"reference":[{"issue":"9","key":"2020122314193354500_CIT0001","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1093\/humrep\/det262","article-title":"Prevalence of polycystic ovary syndrome in women in China: a large community-based study","volume":"28","author":"Li","year":"2013","journal-title":"Hum Reprod."},{"issue":"2","key":"2020122314193354500_CIT0002","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.fertnstert.2013.04.001","article-title":"Prevalence of polycystic ovary syndrome in adolescents","volume":"100","author":"Christensen","year":"2013","journal-title":"Fertil. Steril."},{"issue":"10","key":"2020122314193354500_CIT0003","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/humrep\/des232","article-title":"Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria","volume":"27","author":"Yildiz","year":"2012","journal-title":"Hum Reprod."},{"issue":"12","key":"2020122314193354500_CIT0004","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"2020122314193354500_CIT0005","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede","year":"2018","journal-title":"Hum Reprod."},{"issue":"6","key":"2020122314193354500_CIT0006","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dml036","article-title":"A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome","volume":"12","author":"Boomsma","year":"2006","journal-title":"Hum Reprod Update."},{"issue":"3","key":"2020122314193354500_CIT0007","first-page":"jc20143886","article-title":"The potential implications of a PCOS diagnosis on a woman\u2019s long-term health using data linkage","volume":"100","author":"Hart","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2020122314193354500_CIT0008","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/humupd\/dmu012","article-title":"Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"20","author":"Barry","year":"2014","journal-title":"Hum Reprod Update."},{"issue":"1","key":"2020122314193354500_CIT0009","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1634\/theoncologist.2014-0311","article-title":"A nationwide population-based retrospective cohort study of the risk of uterine, ovarian and breast cancer in women with polycystic ovary syndrome","volume":"20","author":"Shen","year":"2015","journal-title":"Oncologist."},{"issue":"1","key":"2020122314193354500_CIT0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ygyno.2014.11.012","article-title":"Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study","volume":"136","author":"Gottschau","year":"2015","journal-title":"Gynecol Oncol."},{"issue":"6","key":"2020122314193354500_CIT0011","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1590\/S0100-72032013000600003","article-title":"[Clinical manifestations, biochemical, ultrasonographic and metabolic of polycystic ovary syndrome in adolescents]","volume":"35","author":"Rehme","year":"2013","journal-title":"Rev Bras Ginecol Obstet."},{"issue":"6","key":"2020122314193354500_CIT0012","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jpag.2012.07.006","article-title":"Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents","volume":"25","author":"Li","year":"2012","journal-title":"J Pediatr Adolesc Gynecol."},{"issue":"1","key":"2020122314193354500_CIT0013","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jpag.2009.04.004","article-title":"Characteristics of adolescents presenting to a multidisciplinary clinic for polycystic ovarian syndrome","volume":"23","author":"Bekx","year":"2010","journal-title":"J Pediatr Adolesc Gynecol."},{"issue":"1","key":"2020122314193354500_CIT0014","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jadohealth.2013.12.020","article-title":"Diagnosing dysglycemia in adolescents with polycystic ovary syndrome","volume":"55","author":"Gooding","year":"2014","journal-title":"J Adolesc Health."},{"issue":"1","key":"2020122314193354500_CIT0015","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1399-5448.2012.00902.x","article-title":"Polycystic ovary syndrome in adolescence: impaired glucose tolerance occurs across the spectrum of BMI","volume":"14","author":"Flannery","year":"2013","journal-title":"Pediatr Diabetes."},{"issue":"3","key":"2020122314193354500_CIT0016","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1210\/jcem.87.3.8305","article-title":"Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome","volume":"87","author":"Palmert","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2020122314193354500_CIT0017","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/humupd\/dmy007","article-title":"Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression","volume":"24","author":"Kakoly","year":"2018","journal-title":"Hum Reprod Update."},{"issue":"4","key":"2020122314193354500_CIT0018","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Moran","year":"2010","journal-title":"Hum Reprod Update."},{"issue":"5","key":"2020122314193354500_CIT0019","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1552-6909.2011.01279.x","article-title":"Health-related quality of life among adolescents with polycystic ovary syndrome","volume":"40","author":"Jones","year":"2011","journal-title":"J Obstet Gynecol Neonatal Nurs."},{"issue":"4","key":"2020122314193354500_CIT0020","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/0898010111398660","article-title":"Managing polycystic ovary syndrome: what our patients are telling us","volume":"29","author":"Crete","year":"2011","journal-title":"J Holist Nurs."},{"issue":"2","key":"2020122314193354500_CIT0021","doi-asserted-by":"crossref","first-page":"e13612","DOI":"10.5812\/ijem.13612","article-title":"The experience of women affected by polycystic ovary syndrome: a qualitative study from iran","volume":"12","author":"Nasiri Amiri","year":"2014","journal-title":"Int J Endocrinol Metab."},{"issue":"4","key":"2020122314193354500_CIT0022","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1530\/EJE-14-0252","article-title":"European survey of diagnosis and management of the polycystic ovary syndrome: results of the ESE PCOS Special Interest Group\u2019s Questionnaire","volume":"171","author":"Conway","year":"2014","journal-title":"Eur J Endocrinol."},{"issue":"4","key":"2020122314193354500_CIT0023","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jpag.2013.03.007","article-title":"Differences in the management of adolescents with polycystic ovary syndrome across pediatric specialties","volume":"26","author":"Auble","year":"2013","journal-title":"J Pediatr Adolesc Gynecol."},{"issue":"5","key":"2020122314193354500_CIT0024","doi-asserted-by":"crossref","first-page":"e20154089","DOI":"10.1542\/peds.2015-4089","article-title":"Metformin or oral contraceptives for adolescents with polycystic ovarian syndrome: a meta-analysis","volume":"137","author":"Al Khalifah","year":"2016","journal-title":"Pediatrics."},{"key":"2020122314193354500_CIT0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13643-015-0105-4","article-title":"The effectiveness and safety of treatments used for polycystic ovarian syndrome management in adolescents: a systematic review and network meta-analysis protocol","volume":"4","author":"Al Khalifah","year":"2015","journal-title":"Syst Rev."},{"author":"Al Khalifah","key":"2020122314193354500_CIT0026","article-title":"Efficacy of treatments for polycystic ovarian syndrome management in adolescents: a systematic review and network meta-analysis"},{"key":"2020122314193354500_CIT0027","doi-asserted-by":"crossref","first-page":"g5630","DOI":"10.1136\/bmj.g5630","article-title":"A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis","volume":"349","author":"Puhan","year":"2014","journal-title":"BMJ."},{"issue":"1","key":"2020122314193354500_CIT0028","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12887-018-1132-9","article-title":"Network meta-analysis: users\u2019 guide for pediatricians","volume":"18","author":"Al Khalifah","year":"2018","journal-title":"BMC Pediatr."},{"key":"2020122314193354500_CIT0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jclinepi.2019.04.018","article-title":"Development of the Grading of Recommendations Assessment, Development and Evaluation (GRADE) summary of findings (SoF) table for network meta-analysis","volume":"115","author":"Yepes-Nunez","year":"2019","journal-title":"J Clin Epidemiol."},{"issue":"4","key":"2020122314193354500_CIT0030","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/1467-9868.00353","article-title":"Bayesian measures of model complexity and fit","volume":"64","author":"Spiegelhalter","year":"2002","journal-title":"J R Stat Soc Series B Stat Methodol."},{"issue":"7-8","key":"2020122314193354500_CIT0031","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis","volume":"29","author":"Dias","year":"2010","journal-title":"Stat Med."},{"volume-title":"gemtc: Network Meta-Analysis Using Bayesian Methods. R package version 0.8\u20132 [computer program]","year":"2016","key":"2020122314193354500_CIT0032"},{"issue":"2","key":"2020122314193354500_CIT0033","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"J Clin Epidemiol."},{"issue":"4","key":"2020122314193354500_CIT0034","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.fertnstert.2012.06.035","article-title":"Comparative study of the therapeutic effects of oral contraceptive pills containing desogestrel, cyproterone acetate, and drospirenone in patients with polycystic ovary syndrome","volume":"98","author":"Bhattacharya","year":"2012","journal-title":"Fertil Steril."},{"issue":"9-10","key":"2020122314193354500_CIT0035","first-page":"455","article-title":"Role of the combination spironolactone-norgestimate-estrogen in hirsute women with polycystic ovary syndrome","volume":"59","author":"Hagag","year":"2014","journal-title":"J Reprod Med."},{"issue":"2","key":"2020122314193354500_CIT0036","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.contraception.2010.02.009","article-title":"Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome","volume":"82","author":"Kriplani","year":"2010","journal-title":"Contraception."},{"issue":"6","key":"2020122314193354500_CIT0037","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000479371","article-title":"An international consortium update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence","volume":"88","author":"Ib\u00e1\u00f1ez","year":"2017","journal-title":"Horm Res Paediatr."},{"issue":"11","key":"2020122314193354500_CIT0038","first-page":"CD009038","article-title":"Quadriphasic versus monophasic oral contraceptives for contraception","author":"Van Vliet","year":"2011","journal-title":"Cochrane Database Syst Rev."},{"issue":"11","key":"2020122314193354500_CIT0039","first-page":"CD003553","article-title":"Triphasic versus monophasic oral contraceptives for contraception","volume":"2011","author":"Van Vliet","year":"2011","journal-title":"Cochrane Database Syst Rev."},{"issue":"4","key":"2020122314193354500_CIT0040","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3109\/13625187.2013.780202","article-title":"Efficacy and bleeding profile of a combined oral contraceptive containing oestradiol valerate\/dienogest: a pooled analysis of three studies conducted in North America and Europe","volume":"18","author":"Nelson","year":"2013","journal-title":"Eur J Contracept Reprod Health Care."},{"issue":"8","key":"2020122314193354500_CIT0041","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2165\/11590260-000000000-00000","article-title":"Cycle control and bleeding pattern of a 24\/4 regimen of drospirenone 3\u2009mg\/ethinylestradiol 20\u2009\u03bcg compared with a 21\/7 regimen of desogestrel 150\u2009\u03bcg\/ethinylestradiol 20\u2009\u03bcg: a pooled analysis","volume":"31","author":"Anttila","year":"2011","journal-title":"Clin Drug Investig."},{"issue":"4","key":"2020122314193354500_CIT0042","doi-asserted-by":"crossref","first-page":"R263","DOI":"10.1677\/ERC-10-0076","article-title":"Hormonal contraception and risk of endometrial cancer: a systematic review","volume":"17","author":"Mueck","year":"2010","journal-title":"Endocr Relat Cancer."},{"issue":"4","key":"2020122314193354500_CIT0043","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1210\/jc.2017-02052","article-title":"Treatment options for hirsutism: a systematic review and network meta-analysis","volume":"103","author":"Barrionuevo","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2020122314193354500_CIT0044","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/humupd\/dmx039","article-title":"Combined oral contraceptives and\/or antiandrogens versus insulin sensitizers for polycystic ovary syndrome: a systematic review and meta-analysis","volume":"24","author":"Luque-Ramirez","year":"2017","journal-title":"Hum Reprod Update"},{"issue":"1","key":"2020122314193354500_CIT0045","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/humrep\/deq301","article-title":"The association between the combined oral contraceptive pill and insulin resistance, dysglycemia and dyslipidemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of observational studies","volume":"26","author":"Halperin","year":"2011","journal-title":"Hum Reprod."},{"issue":"3","key":"2020122314193354500_CIT0046","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s12020-016-0972-z","article-title":"Long-term effects of oral contraceptives on the prevalence of diabetes in post-menopausal women: 2007-2012 KNHANES","volume":"53","author":"Kim","year":"2016","journal-title":"Endocrine."},{"issue":"3","key":"2020122314193354500_CIT0047","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1179\/2050854914Y.0000000023","article-title":"The effects of hormonal contraceptives on glycemic regulation","volume":"81","author":"Cort\u00e9s","year":"2014","journal-title":"Linacre Q."},{"issue":"9017","key":"2020122314193354500_CIT0048","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","article-title":"Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies","volume":"347","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"1996","journal-title":"Lancet."},{"issue":"4","key":"2020122314193354500_CIT0049","first-page":"265","article-title":"Early oral contraceptive use and premenopausal breast cancer\u2013a review of studies performed in southern Sweden","volume":"15","author":"Olsson","year":"1991","journal-title":"Cancer Detect Prev."},{"issue":"6","key":"2020122314193354500_CIT0050","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.dsx.2018.03.014","article-title":"Risk of metabolic syndrome in adolescents with polycystic ovarian syndrome: a systematic review and meta-analysis","volume":"12","author":"Fazleen","year":"2018","journal-title":"Diabetes Metab Syndr."},{"issue":"3","key":"2020122314193354500_CIT0051","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1471-0528.2010.02799.x","article-title":"Health-related quality of life and psychological distress in polycystic ovary syndrome: a hidden facet in South Asian women","volume":"118","author":"Kumarapeli","year":"2011","journal-title":"BJOG."},{"issue":"21-22","key":"2020122314193354500_CIT0052","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1111\/jocn.14624","article-title":"Health-related quality of life in diabetes mellitus and its social, demographic and clinical determinants: a nationwide cross-sectional survey","volume":"27","author":"Rodr\u00edguez-Almagro","year":"2018","journal-title":"J Clin Nurs."},{"issue":"5","key":"2020122314193354500_CIT0053","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr Rev."}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/jendso\/bvaa155\/33934942\/bvaa155.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jes\/article-pdf\/5\/1\/bvaa155\/35098571\/bvaa155.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jes\/article-pdf\/5\/1\/bvaa155\/35098571\/bvaa155.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T19:21:05Z","timestamp":1608751265000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvaa155\/5929644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,17]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvaa155","relation":{},"ISSN":["2472-1972"],"issn-type":[{"type":"electronic","value":"2472-1972"}],"subject":[],"published-other":{"date-parts":[[2021,1]]},"published":{"date-parts":[[2020,10,17]]},"article-number":"bvaa155"}}